FDA Panel Finds a Peptide It Doesn't Like
(MedPage Today) -- An FDA panel on Friday continued to recommend loosening compounding restrictions for all but one of the peptides it reviewed, despite safety concerns from agency scientists for all of them.
During the second day of deliberations...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
같은 사건, 다른 제목
FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?
F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
FDA panel considers loosening regulations on certain unapproved peptides
Inside the unconventional FDA panel that could reshape the peptide industry
FDA Panel Finds a Peptide It Doesn't Like
FDA panel rejects only 1 peptide despite backlash
RFK Jr.’s peptide push narrowly gains backing from FDA advisers despite objections from scientists
FDA advisory panel narrowly rejects compounding of one peptide, back another
+1